Lv3
240 积分 2024-01-08 加入
Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations
2个月前
已完结
Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study)
3个月前
已完结
PL04.13 Aumolertinib Maintenance after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer: Interim Results of the Phase III Study (POLESTAR)
4个月前
已完结
Timeliness of EGFR/ALK inhibitor treatment and survival in lung cancer: A population-based analysis
4个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
4个月前
已完结
The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials
6个月前
已完结
Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer
6个月前
已完结
First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer
6个月前
已完结
Targeting Acquired and Intrinsic Resistance Mechanisms in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
7个月前
已完结
EGFR Mutations and Lung Cancer
7个月前
已完结
皖公网安备34019202002308
